Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06ZBV
|
|||
| Former ID |
DNC013691
|
|||
| Drug Name |
CARCININE
|
|||
| Synonyms |
Carcinine; 56897-53-1; N-(2-(1H-Imidazol-5-yl)ethyl)-3-aminopropanamide; beta-Alanylhistamine; UNII-WIV0W167TC; WIV0W167TC; N-[2-(1H-imidazol-5-yl)ethyl]-beta-alaninamide; SPBio_002343; beta-alaninylhistamine; N-beta-alanylhistamine; AC1L1DZE; Prestwick2_000422; Prestwick1_000422; Prestwick0_000422; Prestwick3_000422; Lopac-C-2321; AC1Q5P6Q; n-[2-(1h-imidazol-5-yl)ethyl]-; A-alaninamide; Lopac0_000210; BSPBio_000404; KSC921E6R; MLS002153803; SCHEMBL2819350; CHEMBL461024; BPBio1_000446; SCHEMBL19051459; CHEBI:95262; CTK8C1268
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H14N4O
|
|||
| Canonical SMILES |
C1=C(NC=N1)CCNC(=O)CCN
|
|||
| InChI |
1S/C8H14N4O/c9-3-1-8(13)11-4-2-7-5-10-6-12-7/h5-6H,1-4,9H2,(H,10,12)(H,11,13)
|
|||
| InChIKey |
ANRUJJLGVODXIK-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 56897-53-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:95262
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. J Med Chem. 2008 Sep 11;51(17):5423-30. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.